James J. Kavanaugh - 26 Feb 2026 Form 4 Insider Report for INTERNATIONAL BUSINESS MACHINES CORP (IBM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Feb 2026, 16:54:55 UTC
Prior SEC filing
23 Feb 2026
Next SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
L. Mallardi on behalf of J. J. Kavanaugh

Key filing fact

James J. Kavanaugh filed Form 4 for INTERNATIONAL BUSINESS MACHINES CORP (IBM) on 27 Feb 2026.

Key facts

  • This page summarizes James J. Kavanaugh's Form 4 filing for INTERNATIONAL BUSINESS MACHINES CORP (IBM).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 27 Feb 2026, 16:54.

Change

  • Previous filing in this sequence was filed on 23 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001433640 Primary reporting owner

KAVANAUGH JAMES J

Relationship
Sr. VP and CFO
Address
IBM CORPORATION, ONE NEW ORCHARD ROAD, ARMONK
Signature
L. Mallardi on behalf of J. J. Kavanaugh
Signature date
27 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IBM transaction Derivative

Rst. Stock Unit

Award

Transaction value
$0
Shares
+10,364
Change %
Price
$0.000000
Shares after
10,364
Date
26 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,364
Exercise price
$0.000000
Footnotes
F1
IBM transaction Derivative

Emp. Stock Option (right to buy)

Award

Transaction value
$0
Shares
+41,455
Change %
Price
$0.000000
Shares after
41,455
Date
26 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
41,455
Exercise price
$243.22
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 2,591 of these units on February 26, 2027, 2,591 of these units on February 26, 2028, 2,591 of these units on February 26, 2029, and 2,591 of these units on February 26, 2030.

Footnote F2

These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown. All expire on the expiration date shown above.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .